Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
technetium Tc 99m-labeled silk fibroin nanoparticles
- Development stage
- Preclinical
- Lead developer
- Hospital Universitario Virgen de la Arrixaca
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Gamma Emitters → Radiopharmaceuticals, Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous
01
Overview
Technetium Tc 99m-labeled silk fibroin nanoparticles is a radiolabeled polymeric nanoparticle formulation consisting of silk fibroin nanoparticles (SFN) directly labeled with the gamma-emitting radionuclide technetium-99m (Tc-99m). Developed by researchers in Spain, including the Hospital Clínico Universitario Virgen de la Arrixaca, the Instituto Murciano de Investigación Biosanitaria (IMIB)-Arrixaca, and the Instituto Murciano de Investigación y Desarrollo Agrario y Alimentario (IMIDA), this agent is designed as a diagnostic imaging probe for single-photon emission computed tomography (SPECT). It is primarily utilized in preclinical research to evaluate the in vivo biodistribution, pharmacokinetics, and stability of silk fibroin-based drug delivery systems.
- Other names
- [99mTc]Tc-SFN99mTc-SFN99mTc-labeled silk fibroin nanoparticlestechnetium Tc 99m silk fibroin nanoparticles
Beyond the preview
Go deeper on technetium Tc 99m-labeled silk fibroin nanoparticles.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on technetium Tc 99m-labeled silk fibroin nanoparticles.